Brachial Plexopathies

Update on Treatment

Elena Shanina, Bing Liao, Robert Glenn Smith

Research output: Contribution to journalReview article

Abstract

Purpose of review: Brachial plexopathies (BPs) are a heterogeneous group of diseases which can profoundly affect person’s function and quality of life. This review targets current approaches to treatment of different BP types. Recent findings: Although there are multiple BP etiologies, non-traumatic causes are particularly unrecognized by clinicians, leading to misdiagnoses and delay in appropriate therapies. Recent data suggests that idiopathic neuralgic amyotrophy may be 50-fold more common than previously thought, with poorer outcomes than reported unless rapid diagnosis is followed by a multidisciplinary approach to treatment, including surgery for refractory cases. Advances in diagnostic imaging reduce time to treatment, if proper recognition by primary providers leads to rapid referral to neurologists. Due to rarity, heterogeneity, and overlap of different BP syndromes, development of treatment strategies is still based on case series and retrospective studies. Despite advances in surgical therapies, there are no randomized trials to guide optimal approaches to treatment in either traumatic or non-traumatic cases. Summary: Recent advances in imaging and surgical therapies may significantly improve clinical outcomes for patients with BPs, if rapid diagnosis of these often under-recognized conditions can be substantially improved to optimize approach to management. Controlled trials are still needed to optimize therapeutic strategies.

Original languageEnglish (US)
Article number24
JournalCurrent Treatment Options in Neurology
Volume21
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Brachial Plexus Neuropathies
Therapeutics
Brachial Plexus Neuritis
Diagnostic Imaging
Diagnostic Errors
Referral and Consultation
Retrospective Studies
Quality of Life

Keywords

  • Brachial plexopathy
  • Brachial plexus injury
  • Neuralgic amyotrophy

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Brachial Plexopathies : Update on Treatment. / Shanina, Elena; Liao, Bing; Smith, Robert Glenn.

In: Current Treatment Options in Neurology, Vol. 21, No. 5, 24, 01.05.2019.

Research output: Contribution to journalReview article

Shanina, Elena ; Liao, Bing ; Smith, Robert Glenn. / Brachial Plexopathies : Update on Treatment. In: Current Treatment Options in Neurology. 2019 ; Vol. 21, No. 5.
@article{5595859a6a4442289055fa952b3b1368,
title = "Brachial Plexopathies: Update on Treatment",
abstract = "Purpose of review: Brachial plexopathies (BPs) are a heterogeneous group of diseases which can profoundly affect person’s function and quality of life. This review targets current approaches to treatment of different BP types. Recent findings: Although there are multiple BP etiologies, non-traumatic causes are particularly unrecognized by clinicians, leading to misdiagnoses and delay in appropriate therapies. Recent data suggests that idiopathic neuralgic amyotrophy may be 50-fold more common than previously thought, with poorer outcomes than reported unless rapid diagnosis is followed by a multidisciplinary approach to treatment, including surgery for refractory cases. Advances in diagnostic imaging reduce time to treatment, if proper recognition by primary providers leads to rapid referral to neurologists. Due to rarity, heterogeneity, and overlap of different BP syndromes, development of treatment strategies is still based on case series and retrospective studies. Despite advances in surgical therapies, there are no randomized trials to guide optimal approaches to treatment in either traumatic or non-traumatic cases. Summary: Recent advances in imaging and surgical therapies may significantly improve clinical outcomes for patients with BPs, if rapid diagnosis of these often under-recognized conditions can be substantially improved to optimize approach to management. Controlled trials are still needed to optimize therapeutic strategies.",
keywords = "Brachial plexopathy, Brachial plexus injury, Neuralgic amyotrophy",
author = "Elena Shanina and Bing Liao and Smith, {Robert Glenn}",
year = "2019",
month = "5",
day = "1",
doi = "10.1007/s11940-019-0562-5",
language = "English (US)",
volume = "21",
journal = "Current Treatment Options in Neurology",
issn = "1092-8480",
publisher = "Current Science, Inc.",
number = "5",

}

TY - JOUR

T1 - Brachial Plexopathies

T2 - Update on Treatment

AU - Shanina, Elena

AU - Liao, Bing

AU - Smith, Robert Glenn

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Purpose of review: Brachial plexopathies (BPs) are a heterogeneous group of diseases which can profoundly affect person’s function and quality of life. This review targets current approaches to treatment of different BP types. Recent findings: Although there are multiple BP etiologies, non-traumatic causes are particularly unrecognized by clinicians, leading to misdiagnoses and delay in appropriate therapies. Recent data suggests that idiopathic neuralgic amyotrophy may be 50-fold more common than previously thought, with poorer outcomes than reported unless rapid diagnosis is followed by a multidisciplinary approach to treatment, including surgery for refractory cases. Advances in diagnostic imaging reduce time to treatment, if proper recognition by primary providers leads to rapid referral to neurologists. Due to rarity, heterogeneity, and overlap of different BP syndromes, development of treatment strategies is still based on case series and retrospective studies. Despite advances in surgical therapies, there are no randomized trials to guide optimal approaches to treatment in either traumatic or non-traumatic cases. Summary: Recent advances in imaging and surgical therapies may significantly improve clinical outcomes for patients with BPs, if rapid diagnosis of these often under-recognized conditions can be substantially improved to optimize approach to management. Controlled trials are still needed to optimize therapeutic strategies.

AB - Purpose of review: Brachial plexopathies (BPs) are a heterogeneous group of diseases which can profoundly affect person’s function and quality of life. This review targets current approaches to treatment of different BP types. Recent findings: Although there are multiple BP etiologies, non-traumatic causes are particularly unrecognized by clinicians, leading to misdiagnoses and delay in appropriate therapies. Recent data suggests that idiopathic neuralgic amyotrophy may be 50-fold more common than previously thought, with poorer outcomes than reported unless rapid diagnosis is followed by a multidisciplinary approach to treatment, including surgery for refractory cases. Advances in diagnostic imaging reduce time to treatment, if proper recognition by primary providers leads to rapid referral to neurologists. Due to rarity, heterogeneity, and overlap of different BP syndromes, development of treatment strategies is still based on case series and retrospective studies. Despite advances in surgical therapies, there are no randomized trials to guide optimal approaches to treatment in either traumatic or non-traumatic cases. Summary: Recent advances in imaging and surgical therapies may significantly improve clinical outcomes for patients with BPs, if rapid diagnosis of these often under-recognized conditions can be substantially improved to optimize approach to management. Controlled trials are still needed to optimize therapeutic strategies.

KW - Brachial plexopathy

KW - Brachial plexus injury

KW - Neuralgic amyotrophy

UR - http://www.scopus.com/inward/record.url?scp=85065030672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065030672&partnerID=8YFLogxK

U2 - 10.1007/s11940-019-0562-5

DO - 10.1007/s11940-019-0562-5

M3 - Review article

VL - 21

JO - Current Treatment Options in Neurology

JF - Current Treatment Options in Neurology

SN - 1092-8480

IS - 5

M1 - 24

ER -